Fmr LLC Cuts Position in Amedisys, Inc. (NASDAQ:AMED)

Fmr LLC reduced its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 50.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 3,213 shares of the health services provider’s stock after selling 3,283 shares during the period. Fmr LLC’s holdings in Amedisys were worth $310,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in AMED. KBC Group NV purchased a new position in Amedisys in the third quarter valued at about $63,000. Innealta Capital LLC acquired a new stake in shares of Amedisys in the 2nd quarter worth approximately $64,000. Signaturefd LLC increased its stake in Amedisys by 88.2% in the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after purchasing an additional 530 shares in the last quarter. CWM LLC raised its holdings in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new stake in Amedisys during the third quarter worth $243,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Trading Up 0.8 %

Shares of AMED stock opened at $84.47 on Friday. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The business has a fifty day simple moving average of $91.75 and a 200-day simple moving average of $94.68. The stock has a market cap of $2.77 billion, a P/E ratio of 33.52, a P/E/G ratio of 1.84 and a beta of 0.73.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $587.67 million during the quarter, compared to analysts’ expectations of $586.75 million. During the same period last year, the company earned $0.98 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. On average, analysts forecast that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.